Biocatalysis As Useful Tool in Asymmetric Synthesis: an Assessment of Recently Granted Patents (2014–2019)

Total Page:16

File Type:pdf, Size:1020Kb

Biocatalysis As Useful Tool in Asymmetric Synthesis: an Assessment of Recently Granted Patents (2014–2019) catalysts Review Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019) Pablo Domínguez de María 1,*, Gonzalo de Gonzalo 2,* and Andrés R. Alcántara 3,* 1 Sustainable Momentum, SL. Av. Ansite 3, 4–6, E-35011 Las Palmas Gran Canaria, Spain 2 Organic Chemistry Departament, University of Sevilla, c/ Profesor García González 2, 41012 Sevilla, Spain 3 Department of Chemistry in Pharmaceutical Sciences, Section of Organic Chemistry (Pharmaceutical Chemistry), Faculty of Pharmacy, Complutense University of Madrid, Plaza de Ramón y Cajal, s/n., E-28040 Madrid, Spain * Correspondence: [email protected] (P.D.d.M.); [email protected] (G.d.G.); [email protected] (A.R.A.); Tel.: +34-60-956-52-37 (P.D.d.M.); +34-95-455-99-97 (G.d.G.); +34-91-394-18-20 (A.R.A.) Received: 6 September 2019; Accepted: 22 September 2019; Published: 25 September 2019 Abstract: The broad interdisciplinary nature of biocatalysis fosters innovation, as different technical fields are interconnected and synergized. A way to depict that innovation is by conducting a survey on patent activities. This paper analyses the intellectual property activities of the last five years (2014–2019) with a specific focus on biocatalysis applied to asymmetric synthesis. Furthermore, to reflect the inventive and innovative steps, only patents that were granted during that period are considered. Patent searches using several keywords (e.g., enzyme names) have been conducted by using several patent engine servers (e.g., Espacenet, SciFinder, Google Patents), with focus on granted patents during the period 2014–2019. Around 200 granted patents have been identified, covering all enzyme types. The inventive pattern focuses on the protection of novel protein sequences, as well as on new substrates. In some other cases, combined processes, multi-step enzymatic reactions, as well as process conditions are the innovative basis. Both industries and academic groups are active in patenting. As a conclusion of this survey, we can assert that biocatalysis is increasingly recognized as a useful tool for asymmetric synthesis and being considered as an innovative option to build IP and protect synthetic routes. Keywords: biocatalysis; asymmetric synthesis; patents; lipases; oxidoreductases; lyases; transaminases 1. Motivation. The Role of Granted Patents as Key Actors in Innovation Biocatalysis is currently recognized as a mature technology for asymmetric synthesis, based on the excellent selectivity (enantio-, chemo, and regio-) that enzymes often display in many chemical processes. The field has experienced a tremendous development when emerging Molecular Biology techniques, used to produce and design enzymes, have been synergized with both process-development concepts (batch to continuous reactors) and medium engineering strategies (non-aqueous media, immobilization, etc.). As a result, biocatalysis can fulfil, in many cases, the demands of modern organic synthesis, which must align a high selectivity and efficiency with sustainability and tight economic figures. As a result, an increasing number of industrial processes have been successfully established, comprising many diverse examples using free enzymes, whole cells, systems biocatalysis, multi-step processes, etc. [1–19]. The abovementioned broad interdisciplinarity profile makes biocatalysis in a fertile landscape for innovation. It is common that researchers of different backgrounds (chemistry, biology, engineering, etc.) Catalysts 2019, 9, 802; doi:10.3390/catal9100802 www.mdpi.com/journal/catalysts Catalysts 2019, 9, 802 2 of 42 Catalysts 2019, 9, x FOR PEER REVIEW 2 of 41 cooperate closely in setting up new enzymatic reactors [20–23]. Overall, each biocatalytic industrial engineering, etc.) cooperate closely in setting up new enzymatic reactors [20–23]. Overall, each reactionbiocatalytic contains industrial highly reaction evolved contains parts, highly which ev areolved not parts, standing which alone, are not but standing that do alone, form but a robustthat processdo form when a robust all of process them when are combined all of them smartly. are combined Some smartly. key concepts Some key for concepts industrial for biocatalysisindustrial maybiocatalysis be: i) designed may be: enzymei) designed variants enzyme with variants improved with selectivity,improved selectivity, high resistance high resistance to chemicals, to thermostability,chemicals, thermostability, etc. [24–30]; etc. ii) bio-based [24–30]; ii) (non-conventional)bio-based (non-conventional) solvents solv usedents as co-solventsused as co-solvents in water, orin as water, biphasic or as systems biphasic [systems31–38]; [31–38]; neoteric neoteric solvents, solvents, such assuch deep as deep eutectic eutectic solvents solvents (DES) (DES) [ 39[39––44]; iii)44] whole-cells ; iii) whole-cells[45–48 [45–48],], immobilization immobilization [49 –[49–56],56], continuous continuous processes, processes, etc. [12,23,57,58]; [12,23,57,58]; and and iv) iv) metricsmetrics [59 [59–62],–62], high high productivities productivities to to assure assure anan industrially-soundindustrially-sound reaction. reaction. ToTo obtain obtain deeper deeper insights insights into into these these expectedexpected innovations,innovations, this this paper paper discloses discloses a apatent patent survey survey relatedrelated to biocatalysisto biocatalysis applied applied to asymmetric to asymmetric synthesis. synthesis. Although Although this genre this of studiesgenre of is (surprisingly)studies is rather(surprisingly) scarce in the rather open scarce literature in the [8 open,63,64 literature], we believe [8,63,64], that the we approach believe that may the nicely approach reflect may the nicely modern trendsreflect in the the modern field, provided trends in by the academic field, provided and industrial by academic groups, and industrial and comprising groups, di andfferent comprising enzymes anddifferent chemical enzymes processes. and chemical Importantly, processes. to further Importan refinetly, theto further innovation refine assessment,the innovation the assessment, focus of the studythe isfocus put of solely the study on those is put patents solely thaton those have patent been granteds that have over been the granted last five over years the (2014–June last five years 2019). Remarkably,(2014–June granted 2019). Remarkably, patents may granted provide patents further may proofs provide on the further necessary proofs steps on the of necessary novelty, innovation, steps of andnovelty, resolution innovation, of industrial and resolution problems, of industrial as demanded problems, for intellectual as demanded property for intellectual (IP) rights. property To simplify (IP) rights. To simplify the reading of the article, the granted patents are discussed by enzyme types, the reading of the article, the granted patents are discussed by enzyme types, covering several relevant covering several relevant case studies. Moreover, the focus of the article is strictly scientific, and no case studies. Moreover, the focus of the article is strictly scientific, and no information regarding information regarding the countries in which the invention is granted, nor whether or not patent fees the countries in which the invention is granted, nor whether or not patent fees are being satisfied, are being satisfied, is provided. It must be noted, however, that readers can easily retrieve that is provided. It must be noted, however, that readers can easily retrieve that information from the patent information from the patent servers, by simply tracking the patent number provided in the servers,references. by simply To follow tracking a consistency the patent with number publication provided rules, in thethe references.years denoted To followin the references a consistency are the with publicationpublication rules, years; the in years all cases, denoted the ineffective the references dates of are those the granted publication patents years; mentioned in all cases, in this the article effective datesare ofincluded those grantedbetween patents2014–2019, mentioned and it can in be this retriev articleed from are included patent servers between as well. 2014–2019, According and to itthe can besurvey, retrieved around from 200 patent patents servers related as to well. biocatalysis According have tobeen the successfully survey, around granted 200 within patents the relatedlast five to biocatalysisyears, as shown have been in Figure successfully 1. granted within the last five years, as shown in Figure1. Figure 1. Patents granted in 2014–2019 employing the most usual types of enzymes, according to Figure 1. Patents granted in 2014–2019 employing the most usual types of enzymes, according to severalseveral patent patent engine engine servers servers (e.g., (e.g., Espacenet, Espacenet, SciFinder,SciFinder, GoogleGoogle Patents). Notably,Notably, examples examples for for all all enzyme enzyme typestypes havehave beenbeen found, for for asymmetric asymmetric synthesis synthesis purposes, purposes, andand the the main main strategies strategies to to achieve achieve patentabilitypatentability are either the the protection protection of of known known enzymes enzymes and and variantsvariants with with di differentfferent sequences sequences (covering up up to to so someme homology), homology), or the or theuse useof novel of novel substrates substrates for forthe the intended intended reactions, reactions, or or a acombination combination of of both both approaches. approaches.
Recommended publications
  • Biomolecules
    CHAPTER 3 Biomolecules 3.1 Carbohydrates In the previous chapter you have learnt about the cell and 3.2 Fatty Acids and its organelles. Each organelle has distinct structure and Lipids therefore performs different function. For example, cell membrane is made up of lipids and proteins. Cell wall is 3.3 Amino Acids made up of carbohydrates. Chromosomes are made up of 3.4 Protein Structure protein and nucleic acid, i.e., DNA and ribosomes are made 3.5 Nucleic Acids up of protein and nucleic acids, i.e., RNA. These ingredients of cellular organelles are also called macromolecules or biomolecules. There are four major types of biomolecules— carbohydrates, proteins, lipids and nucleic acids. Apart from being structural entities of the cell, these biomolecules play important functions in cellular processes. In this chapter you will study the structure and functions of these biomolecules. 3.1 CARBOHYDRATES Carbohydrates are one of the most abundant classes of biomolecules in nature and found widely distributed in all life forms. Chemically, they are aldehyde and ketone derivatives of the polyhydric alcohols. Major role of carbohydrates in living organisms is to function as a primary source of energy. These molecules also serve as energy stores, 2021-22 Chapter 3 Carbohydrade Final 30.018.2018.indd 50 11/14/2019 10:11:16 AM 51 BIOMOLECULES metabolic intermediates, and one of the major components of bacterial and plant cell wall. Also, these are part of DNA and RNA, which you will study later in this chapter. The cell walls of bacteria and plants are made up of polymers of carbohydrates.
    [Show full text]
  • C9-14 Aliphatic [2-25% Aromatic] Hydrocarbon Solvents Category SIAP
    CoCAM 2, 17-19 April 2012 BIAC/ICCA SIDS INITIAL ASSESSMENT PROFILE Chemical C -C Aliphatic [2-25% aromatic] Hydrocarbon Solvents Category Category 9 14 Substance Name CAS Number Stoddard solvent 8052-41-3 Chemical Names Kerosine, petroleum, hydrodesulfurized 64742-81-0 and CAS Naphtha, petroleum, hydrodesulfurized heavy 64742-82-1 Registry Solvent naphtha, petroleum, medium aliphatic 64742-88-7 Numbers Note: Substances in this category are also commonly known as mineral spirits, white spirits, or Stoddard solvent. CAS Number Chemical Description † 8052-41-3 Includes C8 to C14 branched, linear, and cyclic paraffins and aromatics (6 to 18%), <50ppmV benzene † 64742-81-0 Includes C9 to C14 branched, linear, and cyclic paraffins and aromatics (10 to Structural 25%), <100 ppmV benzene Formula † and CAS 64742-82-1 Includes C8 to C13 branched, linear, and cyclic paraffins and aromatics (15 to 25%), <100 ppmV benzene Registry † Numbers 64742-88-7 Includes C8 to C13 branched, linear, and cyclic paraffins and aromatics (14 to 20%), <50 ppmV benzene Individual category member substances are comprised of aliphatic hydrocarbon molecules whose carbon numbers range between C9 and C14; approximately 80% of the aliphatic constituents for a given substance fall within the C9-C14 carbon range and <100 ppmV benzene. In some instances, the carbon range of a test substance is more precisely defined in the test protocol. In these instances, the specific carbon range (e.g. C8-C10, C9-C10, etc.) will be specified in the SIAP. * It should be noted that other substances defined by the same CAS RNs may have boiling ranges outside the range of 143-254° C and that these substances are not covered by the category.
    [Show full text]
  • Thiourea Derivatives of Tröger's Base
    General Papers ARKIVOC 2009 (xiv) 124-134 Thiourea derivatives of Tröger’s base: synthesis, enantioseparation and evaluation in organocatalysis of Michael addition to nitroolefins Delphine Didiera and Sergey Sergeyeva,b* a Université Libre de Bruxelles (ULB), Laboratoire de Chimie des Polymères, CP 206/01, Boulevard du Triomphe, 1050 Brussels, Belgium b University of Antwerp, Department of Chemistry, Groenenborgerlaan 171, 2020 Antwerp, Belgium E-mail: [email protected] Abstract The catalytic activity of racemic thiourea derivatives of Tröger’s base (±)-2–4 in Michael additions of malonate derivatives to trans-β-nitrostyrene was studied. Due to the low basicity of Tröger’s base, the outcome of the addition reactions was strongly dependent on the pKa of the nucleophile. Thiourea catalysts (±)-2, 3 were resolved on the chiral stationary phase Whelk O1. Unfortunately, enantiopure catalysts 2 and 3 showed no stereoselectivity in the Michael addition. Keywords: Tröger’s base, thiourea, Michael addition, catalysis, WhelkO1 Introduction In the recent years, asymmetric organocatalysis has emerged as a competitive, environment- friendlier alternative to catalysis with transition metal complexes. While simple molecules such as derivatives of proline have been receiving a great deal of attention due to their availability, considerable effort has been directed towards searching for novel chiral scaffolds for asymmetric organocatalysis.1 Tröger’s base 1 is a chiral diamine bearing two stereogenic bridge-head nitrogen atoms (Figure 1). The two aromatic rings fused to the central bicyclic framework are almost perpendicular to each other, creating a rigid, V-shaped C2-symmetrical molecular scaffold with a distance of ca. 1nm between the two extremities.2 Due to its chirality and relatively rigid geometry, one would intuitively expect a considerable interest for analogues of Tröger’s base in the field of asymmetric synthesis and catalysis.
    [Show full text]
  • Organic Synthesis: Handout 1
    Prof Tim Donohoe: Strategies and Taccs in Organic Synthesis: Handout 1 Organic Synthesis III 8 x 1hr Lectures: Michaelmas Term Weeks 5-8 2016 Mon at 10am; Wed at 9am Dyson Perrins lecture theatre Copies of this handout will be available at hEp://donohoe.chem.ox.ac.uk/page16/index.html 1/33 Prof Tim Donohoe: Strategies and Taccs in Organic Synthesis: Handout 1 Organic Synthesis III Synopsis 1) Introduc5on to synthesis: (i) Why do we want to synthesise molecules- what sort of molecules do we need to make? (ii) What aspects of selecvity do we need to accomplish a good synthesis (chemo-, regio- and stereoselecvity)? (iii) Protecng group chemistry is central to any syntheAc effort (examples and principles) (iv) What is the perfect synthesis (performed in industry versus academia)? 2) The chiral pool: where does absolute stereochemistry come from? 3) Retrosynthesis- learning to think backwards (revision from first and second year). Importance of making C-C bonds and controlling oxidaAon state. Umpolung 4) Some problems to think about 5) Examples of retrosynthesis/synthesis in ac5on. 6) Ten handy hints for retrosynthesis 7) Soluons to the problems Recommended books: General: Organic Chemistry (Warren et al) Organic Synthesis: The DisconnecRon Approach (S. Warren) Classics in Total Synthesis Volumes I and II (K. C. Nicolaou) The Logic of Chemical Synthesis (E. J. Corey) 2/33 View Article Online / Journal Homepage / Table of Contents for this issue 619461 Strychniqae and BYucine. Pavt XLII. 903 Prof Tim Donohoe: Strategies and Taccs in Organic Synthesis: Handout 1 (i) Why do we want to synthesise complex molecules? Isolated from the Pacific Yew in 1962 Prescribed for prostate, breast and ovarian cancer Unique mode of acRon 1x 100 year old tree = 300 mg Taxol Isolated in 1818- poisonous Stuctural elucidaon took R.
    [Show full text]
  • Improved Catalytic Performance of Carrier-Free Immobilized Lipase by Advanced Cross-Linked Enzyme Aggregates Technology
    Improved Catalytic Performance of Carrier-Free Immobilized Lipase by Advanced Cross-Linked Enzyme Aggregates Technology Xia Jiaojiao Jiangsu University of Science and Technology: Jiangsu University Yan Yan Jiangsu University Bin Zou ( [email protected] ) Jiangsu University https://orcid.org/0000-0003-3816-8776 Adesanya Idowu Onyinye Jiangsu University Research Article Keywords: lipase, carrier-free, immobilization, ionic liquid, stability Posted Date: May 24th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-505612/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/20 Abstract The cross-linked enzyme aggregates (CLEAs) are one of the technologies that quickly immobilize the enzyme without a carrier. This carrier-free immobilization method has the advantages of simple operation, high reusability and low cost. In this study, ionic liquid with amino group (1-aminopropyl-3- methylimidazole bromideIL) was used as the novel functional surface molecule to modify industrialized lipase (Candida rugosa lipase, CRL). The enzymatic properties of the prepared CRL-FIL-CLEAs were investigated. The activity of CRL-FIL-CLEAs (5.51 U/mg protein) was 1.9 times higher than that of CRL- CLEAs without surface modication (2.86 U/mg protein). After incubation at 60℃ for 50 min, CRL-FIL- CLEAs still maintained 61% of its initial activity, while the value for CRL-CLEAs was only 22%. After repeated use for ve times, compared with the 22% residual activity of CRL-CLEAs, the value of CRL-FIL- CLEAs was 51%. Further kinetic analysis indicated that the Km values for CRL-FIL-CLEAs and CRL-CLEAs were 4.80 mM and 8.06 mM, respectively, which was inferred that the anity to substrate was increased after modication.
    [Show full text]
  • Artificial Intelligence for Computer-Aided Synthesis
    ORIGINAL RESEARCH published: 04 August 2020 doi: 10.3389/fceng.2020.00005 Artificial Intelligence for Computer-Aided Synthesis In Flow: Analysis and Selection of Reaction Components Pieter P. Plehiers 1,2, Connor W. Coley 1, Hanyu Gao 1, Florence H. Vermeire 1, Maarten R. Dobbelaere 2, Christian V. Stevens 3, Kevin M. Van Geem 2* and William H. Green 1* 1 Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States, 2 Laboratory for Chemical Technology, Department of Materials, Textiles and Chemical Engineering, Ghent University, Ghent, Belgium, 3 SynBioC Research Group, Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent Edited by: University, Ghent, Belgium René Schenkendorf, Technische Universitat Braunschweig, Germany Computer-aided synthesis has received much attention in recent years. It is a challenging Reviewed by: topic in itself, due to the high dimensionality of chemical and reaction space. It becomes Richard Anthony Bourne, even more challenging when the aim is to suggest syntheses that can be performed in University of Leeds, United Kingdom Alexei Lapkin, continuous flow. Though continuous flow offers many potential benefits, not all reactions University of Cambridge, are suited to be operated continuously. In this work, three machine learning models United Kingdom have been developed to provide an assessment of whether a given reaction may benefit *Correspondence: from continuous operation, what the likelihood of success in continuous flow is for a Kevin M. Van Geem [email protected] certain set of reaction components (i.e., reactants, reagents, solvents, catalysts, and William H. Green products) and, if the likelihood of success is low, which alternative reaction components [email protected] can be considered.
    [Show full text]
  • – with Novozymes Enzymes for Biocatalysis
    Biocatalysis Pregabalin case study Smarter chemical synthesis – with Novozymes enzymes for biocatalysis The new biocatalytic route results in process improvements, reduced organic solvent usage and substantial reduction of waste streams in Pregabalin production. Introduction Biocatalysis is the application of enzymes to replace chemical Using Lipolase®, a commercially available lipase, rac-2- catalysts in synthetic processes. In recent past, the use of carboxyethyl-3-cyano-5-methylhexanoic acid ethyl ester biocatalysis has gained momentum in the chemical and (1) can be resolved to form (S)-2-carboxyethyl-3-cyano-5- pharmaceutical industries. Today, it’s an important tool for methylhexanoic acid (2). Compared to the first-generation medicinal, process and polymer chemists to develop efficient process, this new route substantially improves process and highly attractive organic synthetic processes on an efficiency by setting the stereocenter early in the synthesis and industrial scale. enabling the facile racemization and reuse of (R)-1. The biocatalytic process for Pregabalin has been developed It outperforms the first-generation manufacturing process also by Pfizer to boost efficiency in Pregabalin production using by delivering higher yields of Pregabalin and by resulting in Novozymes Lipolase®. substantial reductions of waste streams, corresponding to a 5-fold decrease in the E-Factor from 86 to 17. Development of the biocatalytic process for Pregabalin involves four stages: • Screening to identify a suitable enzyme • Performing optimization of the enzymatic reaction to optimize throughput and reduce enzyme loading • Exploring a chemical pathway to preserve the enantiopurity of the material already obtained and lead to Pregabalin, and • Developing a procedure for the racemization of (R)-1 Process improvements thanks to the biocatalytic route Pregabalin chemical synthesis H Knovenagel CN condensation cyanation KOH 0 Et02C CO2Et Et02C CO2Et Et02C CO2Et CNDE (1) CN NH2 1.
    [Show full text]
  • BULLETIN for the HISTORY of CHEMISTRY Division of the History of Chemistry of the American Chemical Society
    BULLETIN FOR THE HISTORY OF CHEMISTRY Division of the History of Chemistry of the American Chemical Society VOLUME 29, Number 1 2004 BULLETIN FOR THE HISTORY OF CHEMISTRY VOLUME 29, CONTENTS NUMBER 1 THE 2003 EDELSTEIN AWARD ADDRESS* MAKING CHEMISTRY POPULAR David Knight, University of Durham, England 1 THE DISCOVERY OF LECITHIN, THE FIRST PHOSPHOLIPID Theodore L. Sourkes, McGill University 9 GABRIEL LIPPMANN AND THE CAPILLARY ELECTROMETER John T. Stock, University of Connecticut 16 KHEMYE: CHEMICAL LITERATURE IN YIDDISH Stephen M. Cohen 21 AN EARLY HISTORY OF CHEMISTRY AT TEXAS TECH UNIVERSITY, 1925-1970* Henry J. Shine, Texas Tech University 30 NOYES LABORATORY, AN ACS NATIONAL CHEMICAL LANDMARK: 100 YEARS OF CHEMISTRY AT THE UNIVERSITY OF ILLINOIS Sharon Bertsch McGrayne 45 BOOK REVIEWS 52 The Cover…….See page 24. Bull. Hist. Chem., VOLUME 29, Number 1 (2004) 1 THE 2003 EDELSTEIN AWARD ADDRESS* MAKING CHEMISTRY POPULAR David Knight, University of Durham, England “Chemistry is wonderful,” wrote evenings, and a bright dawn Linus Pauling (1), “I feel sorry for gleamed over a chemically-based people who don’t know anything society. Intellectually, the science about chemistry. They are miss- did not demand the mathematics re- ing an important source of happi- quired for serious pursuit of the sub- ness.” That is not how the science lime science of astronomy. Chem- has universally been seen in our ists like Joseph Priestley thought it time. We would not expect to see the ideal Baconian science in which lecture-rooms crowded out, chem- everyone might join, for its theoreti- ists as stars to be invited to fash- cal structure was still unformed.
    [Show full text]
  • Sugars As the Source of Energized Carbon for Abiogenesis
    Astrobiology Science Conference 2010 (2010) 5095.pdf SUGARS AS THE SOURCE OF ENERGIZED CARBON FOR ABIOGENESIS. A. L. Weber, SETI Institute, NASA Ames Research Center, Mail Stop 239-4, Moffett Field, CA, 94035-1000, [email protected] Abstract: As shown in Figure 1, abiogenesis has sev- eral requirements: (A) a source of organic substrates and chemical energy that drives the synthesis of (B) useful small molecules (ammonia, monomers, metabo- lites, energy molecules), and (C) a second synthetic processs that yields large replicating and catalytic polymers that control (D) the growth and maintenance of a primitive protocell. Furthermore, the required chemical energy must be sustained and effectively coupled to individual reactions to drive biosynthesis at a rate that counters chemical degradation. Energy coupling would have been especially difficult during the origin of life before the development of powerful enzyme catalysts with 3-D active sites. To solve this energy coupling problem we have investigated abio- genesis using sugar substrates whose energized carbon groups drive spontaneous synthetic self-transformation reactions that yield: biometabolites, catalytic mole- cules, energy-rich thioesters, amino acids, plausible alternative nucleobases and cell-like microstructures [1-8]. Recently, we demonstrated that sugars drive the synthesis of ammonia from nitrite [9]. The ability of sugars to drive ammonia synthesis provides a way to generate ammonia at microscopic sites of sugar-based origins processes, thereby eliminating the need for a planet-wide source of photochemically unstable am- monia. Figure 1. Major Synthetic Processes of Abiogenesis. [1] Weber A. L. (1998) Orig. Life Evol. Biosph., 28, 259-270. [2] Weber A.
    [Show full text]
  • Interactions Medicamenteuses Index Des Classes Pharmaco
    INTERACTIONS MEDICAMENTEUSES INDEX DES CLASSES PHARMACO-THERAPEUTIQUES Mise à jour avril 2006 acides biliaires (acide chenodesoxycholique, acide ursodesoxycholique) acidifiants urinaires adrénaline (voie bucco-dentaire ou sous-cutanée) (adrenaline alcalinisants urinaires (acetazolamide, sodium (bicarbonate de), trometamol) alcaloïdes de l'ergot de seigle dopaminergiques (bromocriptine, cabergoline, lisuride, pergolide) alcaloïdes de l'ergot de seigle vasoconstricteurs (dihydroergotamine, ergotamine, methylergometrine) alginates (acide alginique, sodium et de trolamine (alginate de)) alphabloquants à visée urologique (alfuzosine, doxazosine, prazosine, tamsulosine, terazosine) amidons et gélatines (gelatine, hydroxyethylamidon, polygeline) aminosides (amikacine, dibekacine, gentamicine, isepamicine, kanamycine, netilmicine, streptomycine, tobramycine) amprénavir (et, par extrapolation, fosamprénavir) (amprenavir, fosamprenavir) analgésiques morphiniques agonistes (alfentanil, codeine, dextromoramide, dextropropoxyphene, dihydrocodeine, fentanyl, hydromorphone, morphine, oxycodone, pethidine, phenoperidine, remifentanil, sufentanil, tramadol) analgésiques morphiniques de palier II (codeine, dextropropoxyphene, dihydrocodeine, tramadol) analgésiques morphiniques de palier III (alfentanil, dextromoramide, fentanyl, hydromorphone, morphine, oxycodone, pethidine, phenoperidine, remifentanil, sufentanil) analogues de la somatostatine (lanreotide, octreotide) androgènes (danazol, norethandrolone, testosterone) anesthésiques volatils halogénés
    [Show full text]
  • A Reminder… Chirality: a Type of Stereoisomerism
    A Reminder… Same molecular formula, isomers but not identical. constitutional isomers stereoisomers Different in the way their Same connectivity, but different atoms are connected. spatial arrangement. and trans-2-butene cis-2-butene are stereoisomers. Chirality: A Type of Stereoisomerism Any object that cannot be superimposed on its mirror image is chiral. Any object that can be superimposed on its mirror image is achiral. Chirality: A Type of Stereoisomerism Molecules can also be chiral or achiral. How do we know which? Example #1: Is this molecule chiral? 1. If a molecule can be superimposed on its mirror image, it is achiral. achiral. Mirror Plane of Symmetry = Achiral Example #1: Is this molecule chiral? 2. If you can find a mirror plane of symmetry in the molecule, in any achiral. conformation, it is achiral. Can subject unstable conformations to this test. ≡ achiral. Finding Chirality in Molecules Example #2: Is this molecule chiral? 1. If a molecule cannot be superimposed on its mirror image, it is chiral. chiral. The mirror image of a chiral molecule is called its enantiomer. Finding Chirality in Molecules Example #2: Is this molecule chiral? 2. If you cannot find a mirror plane of symmetry in the molecule, in any conformation, it is chiral. chiral. (Or maybe you haven’t looked hard enough.) Pharmacology of Enantiomers (+)-esomeprazole (-)-esomeprazole proton pump inhibitor inactive Prilosec: Mixture of both enantiomers. Patent to AstraZeneca expired 2002. Nexium: (+) enantiomer only. Process patent coverage to 2007. More examples at http://z.umn.edu/2301drugs. (+)-ibuprofen (-)-ibuprofen (+)-carvone (-)-carvone analgesic inactive (but is converted to spearmint oil caraway oil + enantiomer by an enzyme) Each enantiomer is recognized Advil (Wyeth) is a mixture of both enantiomers.
    [Show full text]
  • Part I Principles of Enzyme Catalysis
    j1 Part I Principles of Enzyme Catalysis Enzyme Catalysis in Organic Synthesis, Third Edition. Edited by Karlheinz Drauz, Harald Groger,€ and Oliver May. Ó 2012 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2012 by Wiley-VCH Verlag GmbH & Co. KGaA. j3 1 Introduction – Principles and Historical Landmarks of Enzyme Catalysis in Organic Synthesis Harald Gr€oger and Yasuhisa Asano 1.1 General Remarks Enzyme catalysis in organic synthesis – behind this term stands a technology that today is widely recognized as a first choice opportunity in the preparation of a wide range of chemical compounds. Notably, this is true not only for academic syntheses but also for industrial-scale applications [1]. For numerous molecules the synthetic routes based on enzyme catalysis have turned out to be competitive (and often superior!) compared with classic chemicalaswellaschemocatalyticsynthetic approaches. Thus, enzymatic catalysis is increasingly recognized by organic chemists in both academia and industry as an attractive synthetic tool besides the traditional organic disciplines such as classic synthesis, metal catalysis, and organocatalysis [2]. By means of enzymes a broad range of transformations relevant in organic chemistry can be catalyzed, including, for example, redox reactions, carbon–carbon bond forming reactions, and hydrolytic reactions. Nonetheless, for a long time enzyme catalysis was not realized as a first choice option in organic synthesis. Organic chemists did not use enzymes as catalysts for their envisioned syntheses because of observed (or assumed) disadvantages such as narrow substrate range, limited stability of enzymes under organic reaction conditions, low efficiency when using wild-type strains, and diluted substrate and product solutions, thus leading to non-satisfactory volumetric productivities.
    [Show full text]